April 29- Medical device maker HeartWare International Inc reported a smaller-than-expected first-quarter loss after sales of its heart pump soared 62 percent, sending its shares up 8 percent in after-market trading.
April 29- Medical device maker HeartWare International Inc reported a smaller-than-expected first-quarter loss after sales of its heart pump soared 62 percent, sending its shares up 8 percent after market. Net loss narrowed to $12.9 million, or 87 cents per share, in the quarter ended March 31, from $18.8 million, or $1.33 per share, a year earlier.
**ORCHARD SUPPLY HARDWARE STORES, $2.11, up 42 pct. Telular said it may solicit superior proposals from third parties through may 29, 2013. Germany's Bayer AG has agreed to buy the U.S. contraceptive devices maker for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider.
Germany's Bayer AG has agreed to buy the U.S. contraceptive devices maker for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider. **SINA CORP, $59.74, up 19 pct** YAHOO INC, $24.72, up 0.3 pct.
April 25- Medical device maker Boston Scientific Corp reported better-than-expected first-quarter results on Thursday, which the company said will put it on the path to return to growth. Boston Scientific's operating margin was considerably better than a year ago, Morningstar analyst Debbie Wang said.
Swiss dental implant maker Nobel Biocare Holding AG. For related news, click on LOGITECH INTERNATIONAL. Logitech International said on Thursday it will keep its videoconferencing after a strategic review, focusing mainly on the small to medium sized companies market, adding the unit could produce a positive core earnings this year.
Edwards said that first-quarter net earnings more than doubled, boosted by a large gain from patent litigation with Medtronic Inc. Net income rose to $144.9 million, or $1.24 per share, from $65.1 million, or 55 cents per share, a year ago.
CHICAGO, April 17- In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from Siemens designed to light up brain deposits of tau, an Alzheimer's protein linked with cell death. Terms of the deal with the conglomerate's Siemens Medical Solutions USA unit were not disclosed.
April 17- Medical device maker St. Jude Medical Inc said on Wednesday its quarterly earnings rose as expenses fell. First-quarter net earnings were $222 million, or 78 cents per diluted share, compared with $212 million, or 67 cents per diluted share, in the year ago period.
April 17- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
CHICAGO, April 17- In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from Siemens designed to light up brain deposits of tau, an Alzheimer's protein linked with cell death. Terms of the deal with the conglomerate's Siemens Medical Solutions USA unit were not disclosed.
*Cook County jury awards no damages to plaintiff Carol Strum. April 16- An Illinois jury on Tuesday found in favor of Johnson& Johnson's DePuy orthopedics unit in a second product liability lawsuit over the company's recalled ASR metal hip implant to go to trial, J&J said.
April 10- St. Jude Medical Inc said on Wednesday it received European regulatory approval for a brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
April 10- St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
The FDA said its proposal would require manufacturers to provide clinical data or other evidence proving their devices are safe and effective in order to be approved or remain on the market. The proposals would also require manufacturers to provide inspection reports and submit to the FDA details of any changes made to the device.
WASHINGTON, March 22- A U.S. appeals court ruled on Friday that the Food and Drug Administration acted correctly when it denied fast-track approval of two stem cell-related medical devices made by Cytori Therapeutics Inc..